Cardiovascular Therapeutics

Advanced treatments for heart disease and cardiovascular disorders

Cardiovascular Innovation

Oracle BioTech is at the forefront of cardiovascular drug development, targeting heart failure, coronary artery disease, arrhythmias, and hypertension with breakthrough therapeutic solutions.

Cardiovascular Research

Heart Failure Therapies

Novel mechanisms targeting cardiac remodeling and improving heart function in patients with chronic heart failure.

  • ACE inhibitor combinations
  • Beta-blocker optimization
  • Diuretic innovations
  • Device-drug combinations
Learn More
Cardiac Monitoring

Arrhythmia Management

Advanced antiarrhythmic agents and monitoring solutions for atrial fibrillation and ventricular arrhythmias.

  • Novel ion channel modulators
  • Precision dosing algorithms
  • Real-time monitoring systems
  • Combination therapies
Learn More

Cardiovascular Pipeline

Discovery

4 Programs

Novel targets for heart failure and atherosclerosis prevention.

Preclinical

3 Programs

Cardiac safety and efficacy studies in development.

Phase I

2 Programs

First-in-human studies for novel cardiac therapeutics.

Phase II

1 Program

Proof-of-concept in heart failure patients.

Phase III

1 Program

Registration-enabling study for innovative heart failure therapy.